{"entity":{"id":"cnside-diagnostics","kind":"company","name":"CNSide Diagnostics","aka":[],"tldr":"CNSide captures tumour cells from cerebrospinal fluid to diagnose and track leptomeningeal disease, cancer spread to the linings of the brain and spine that conventional cytology often misses.","summary":"CNSide Diagnostics runs a cerebrospinal fluid assay that captures and counts circulating tumour cells and profiles their molecular markers, used to diagnose leptomeningeal metastases and to follow them over time during treatment. Future of Cancer Care Today notes it often detects cases that conventional cytology misses; it is physician-ordered.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://cnsidediagnostics.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["liquid-biopsy","ctc-capture"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"United States (city not published)","country":"US","companyType":"diagnostics","website":"https://cnsidediagnostics.com/","investors":[],"funding":[]},"route":"/companies/cnside-diagnostics/","neighbours":{"technology":[{"id":"ctc-capture","kind":"technology","name":"Circulating tumour cell capture","route":"/technologies/ctc-capture/"},{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"}]}}